>
The Homeless Industrial Complex:
The Lucid Cosmos Will Have More Range Than Any Tesla
Trump Admin Ends Medicaid Funding For Sex-Change Procedures On Kids
Strong 3D printable elastic polymer resists damage
Vitalik Buterin Says Ethereum Is Betting Its Future On Quantum Security And AI
Everything You Wanted To Know About Building A Cheap AI Setup (That Still Works)...
If They Were Human, They'd Be Arrested. Experts Respond To Rogue AI Breaches
Sodium Ion Batteries Will be 80% Cheaper & Last LONGER!
German startup SAXON Q has introduced a diamond-based quantum computing system...
Elon Musk To Build The Largest Building In The World - 100 Million Square Feet
Bitcoin 'Red Team' Says AI Is Finding 100s Of Critical Exploits Across Core Projects
EG4 Power Pro VS Ruixu Lithi VS Yixiang Budget Battery! Best Selling Battery Showdown!
Insect wings can kill bacteria without any chemicals!
Tesla Never Made An Electric Jet Boat, So This YouTuber Built One Himself

Patient Number Two was born to first-time parents, late 20s, white. The pregnancy was normal and the birth uncomplicated. But after a few months, it became clear something was wrong. The child had ear infection after ear infection and trouble breathing at night. He was small for his age, and by his fifth birthday, still hadn't spoken. He started having seizures. Brain MRIs, molecular analyses, basic genetic testing, scores of doctors; nothing turned up answers. With no further options, in 2015 his family decided to sequence their exomes—the portion of the genome that codes for proteins—to see if he had inherited a genetic disorder from his parents. A single variant showed up: ARID1B.
The mutation suggested he had a disease called Coffin-Siris syndrome. But Patient Number Two didn't have that disease's typical symptoms, like sparse scalp hair and incomplete pinky fingers. So, doctors, including Karen Gripp, who met with Two's family to discuss the exome results, hadn't really considered it. Gripp was doubly surprised when she uploaded a photo of Two's face to Face2Gene. The app, developed by the same programmers who taught Facebook to find your face in your friend's photos, conducted millions of tiny calculations in rapid succession—how much slant in the eye? How narrow is that eyelid fissure? How low are the ears? Quantified, computed, and ranked to suggest the most probable syndromes associated with the facial phenotype. There's even a heat map overlay on the photo that shows which the features are the most indicative match.
"In hindsight it was all clear to me," says Gripp, who is chief of the Division of Medical Genetics at A.I. duPont Hospital for Children in Delaware, and had been seeing the patient for years. "But it hadn't been clear to anyone before." What had taken Patient Number Two's doctors 16 years to find took Face2Gene just a few minutes.

FDNA
Face2Gene takes advantage of the fact that so many genetic conditions have a tell-tale "face"—a unique constellation of features that can provide clues to a potential diagnosis. It is just one of several new technologies taking advantage of how quickly modern computers can analyze, sort, and find patterns across huge reams of data. They are built in fields of artificial intelligence known as deep learning and neural nets—among the most promising to deliver AI's 50-year old promise to revolutionize medicine by recognizing and diagnosing disease.
Genetic syndromes aren't the only diagnoses that could get help from machine learning. The RightEye GeoPref Autism Test can identify the early stages of autism in infants as young as 12 months—the crucial stages where early intervention can make a big difference.